Predict your next investment

Genfleet company logo
HEALTHCARE | Drug Development
genfleet.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series B - II | Alive

Total Raised

$90.81M

Last Raised

$16M | 9 mos ago

About Genfleet

Genfleet is a drug development company focused on cancer and autoimmune diseases.

Genfleet Headquarter Location

No.63, 1000 Nong, Zhangheng Road, Zhangjiang High Tech Park Pudong New District

Shanghai, Shanghai,

China

+86 021-6882 1388

Latest Genfleet News

In the clinic for Oct. 1, 2021

Oct 1, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amo, Antares, Apollomics, Arrowhead, Bausch + Lomb, Braxia, CNS, Edison, Eli Lilly, Genfleet, Gyroscope, I-Mab, Immunic, Inmed, Laurent, Minerva, Oxurion, Regeneron, Ribomic, Roche, Todos Medical, Trevena, Zogenix.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Genfleet

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genfleet is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

14,138 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Genfleet Patents

Genfleet has filed 3 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Human proteins
  • Proteins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/3/2018

3/23/2021

Transcription factors, Cell cycle, Proteins, Experimental cancer drugs, Small nuclear RNA

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/3/2018

00/00/0000

00/00/0000

Grant Date

3/23/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Cell cycle, Proteins, Experimental cancer drugs, Small nuclear RNA

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.